Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer

Oncology Reports

Volumn 6, Issue 1, 1999, Pages 71-73

  Harris, Randall E ^a,b   Kasbari, Samer ^a   Farrar, William B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Breast cancer; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ARTICLE; BODY MASS; BREAST TUMOR; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

ACETAMINOPHEN; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; BODY MASS INDEX; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IBUPROFEN; INCIDENCE; OHIO; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032622310     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.6.1.71     Document Type: Article

References (14)

1. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232-235, 1971.
2. Herschman HR: Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 13: 241-256, 1994.
3. Wu KK: Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles (Review). J Lab Clin Med 128: 242-245, 1996.
4. Karmali RA, Adams L and Trout JR: Plant and marine n-3 fatty acids inhibit experimental metastasis of rat mammary adenocarinoma cells. Prostaglandins Leuko Essent Fatty Acids 48: 309-314, 1993.
5. Ramchurren N and Karmali RA. Effects of gamma-linolenic and dihomo-gamma-linolenic fatty acids on 7.12 dimethylbenz(alpha)anthracene mammary tumors in rats. Prostaglandins Leukot Essent Fatty Acids 53: 95-101, 1995.
6. Marnett LJ: Aspirin and the potential role of prostaalandins in colon cancer. Cancer Res 52: 5575-5589, 1992.
7. Harris RE, Namboodiri KK, Stellman SD and Wynder EL: Breast cancer and NSAID use. Heterogeneity of effect in a case-control study. Prev Med 24: 119-120, 1995.
8. Harris RE, Namboodiri KK and Farrar WB: Epidemiologic study of non-steroidal anti-inflammatory drugs and breast cancer. Oncol Rep 2: 591-592, 1995.
9. Harris RE, Namboodiri KK and Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7: 203-205, 1996.
10. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA and Colditz GA: Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88: 988-993, 1996.
11. Parrett ML, Harris RE, Joarder FS, Ross MS, Clausen KP and Robertson FM: Cyclooxyaenase-2 gene expression in human breast cancer. Int J Oncol 10: 503-507, 1997.
12. Zhao Y, Agarwal VR, Mendelson CR and Simpson ER: Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137: 5739-5742, 1996.
13. Tsuji M, Kawano S, Tsugi S, Sawaoka H, Hiri M and DuBois RN: Cyclooxygenase regulates anaiogenesis induced by colon cancer cells. Cell 93: 706-716, 1998.
14. Harris RE, Robertson FM, Farrar WB and Brueggemeier RW: Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP-19): an extension of the dietary fat hypothesis of breast cancer. Med Hypotheses (In press).